| scholarly article | Q13442814 |
| P2093 | author name string | C. F. Rowley | |
| P2860 | cites work | Monitoring HIV viral load in resource limited settings: still a matter of debate? | Q28485511 |
| Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe | Q28730357 | ||
| Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy | Q28730448 | ||
| How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa | Q28730481 | ||
| Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers | Q33497614 | ||
| A rapid and automated sample-to-result HIV load test for near-patient application | Q83183611 | ||
| Viral load monitoring in resource-limited settings: a medical and public health priority | Q84753788 | ||
| Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature | Q33893797 | ||
| Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection. | Q34042986 | ||
| The use of pooled viral load testing to identify antiretroviral treatment failure | Q34043003 | ||
| Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring | Q34208678 | ||
| Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations | Q34388590 | ||
| HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System | Q34481348 | ||
| Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico. | Q34574727 | ||
| Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting | Q35019884 | ||
| Viral load testing in a resource-limited setting: quality control is critical | Q35049333 | ||
| Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? | Q35185677 | ||
| Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness | Q35217495 | ||
| Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial | Q35541563 | ||
| CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study | Q35541572 | ||
| Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings | Q35636520 | ||
| Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa | Q35848080 | ||
| Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa | Q36279351 | ||
| Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children | Q36379413 | ||
| Performance evaluation of the MBio Diagnostics point-of-care CD4 counter | Q36487333 | ||
| Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings | Q36877987 | ||
| Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study | Q37269681 | ||
| Challenges in implementing HIV load testing in South Africa | Q37708291 | ||
| "What took you so long?" The impact of PEPFAR on the expansion of HIV testing and counseling services in Africa | Q38026484 | ||
| Operational challenges in delivering CD4 diagnostics in sub-Saharan Africa | Q38424306 | ||
| Evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing | Q38630017 | ||
| Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing | Q39166408 | ||
| Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya | Q39320508 | ||
| Botswana's Tebelopele voluntary HIV counseling and testing network: use and client risk factors for HIV infection, 2000-2004. | Q40799675 | ||
| Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso | Q43930767 | ||
| Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service | Q44232113 | ||
| Point-of-care HIV testing at antenatal care and maternity sites: experience in Battambang Province, Cambodia | Q45741040 | ||
| The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy | Q46204322 | ||
| Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study | Q46314408 | ||
| Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa | Q46812897 | ||
| Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy. | Q50591176 | ||
| Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving role. | Q51872423 | ||
| Detection of acute infections during HIV testing in North Carolina. | Q51974681 | ||
| Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. | Q53086018 | ||
| Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay. | Q54320109 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | viral load | Q2528140 |
| P304 | page(s) | 407-12 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Developments in CD4 and viral load monitoring in resource-limited settings | |
| P478 | volume | 58 |
| Q64103754 | AIDS prevention and control in the Yunnan region by T cell subset assessment |
| Q90161657 | Adaptive viral load monitoring frequency to facilitate differentiated care: a modeling study from Rakai, Uganda |
| Q56766086 | Advancing rapid point-of-care viral diagnostics to a clinical setting |
| Q36110189 | Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011-2013: Analysis of Annual Surveys at the Facility Level |
| Q37305580 | CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm3 Versus Universal Eligibility for Antiretroviral Therapy |
| Q28546416 | Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care |
| Q36992861 | Cost-Effectiveness and Quality of Care of a Comprehensive ART Program in Malawi |
| Q35948083 | Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD |
| Q36669337 | Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits |
| Q28395615 | Enabling robust quantitative readout in an equipment-free model of device development |
| Q38782246 | Evaluating facility-based antiretroviral therapy programme effectiveness: a pilot study comparing viral load suppression and retention rates |
| Q37625173 | Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting |
| Q34072721 | HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia |
| Q28271593 | HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing |
| Q37608851 | High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa. |
| Q36101989 | Impact of nurse-delivered community-based CD4 services on facilitating pre-ART care in rural South Africa |
| Q37501613 | Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. |
| Q33576031 | Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings |
| Q38794121 | Improved HIV-1 Viral Load Monitoring Capacity Using Pooled Testing With Marker-Assisted Deconvolution |
| Q89863797 | Leaving no one behind: lessons from implementation of policies for universal HIV treatment to universal health coverage |
| Q35780275 | Malaria Prevalence among Young Infants in Different Transmission Settings, Africa |
| Q36969448 | Microfluidic differential immunocapture biochip for specific leukocyte counting |
| Q54261112 | Parasites may exit immunocompromised northern pig-tailed macaques (Macaca leonina) infected with SIVmac239. |
| Q64063567 | Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya |
| Q39353931 | Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile. |
| Q51835679 | Pooled specimens for HIV RNA monitoring: cheaper, but is it reliable? |
| Q36715819 | Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges |
| Q27347920 | Smartphone-Imaged HIV-1 Reverse-Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) on a Chip from Whole Blood. |
| Q38281773 | The future role of CD4 cell count for monitoring antiretroviral therapy |
| Q64064880 | Toward Improving Accessibility of Point-of-Care Diagnostic Services for Maternal and Child Health in Low- and Middle-Income Countries |
| Q34110875 | WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients |
Search more.